0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Buerger Disease Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-34V5663
Home | Market Reports | Health| Health Conditions
Global Buerger Disease Diagnosis Market Insights Forecast to 2028
BUY CHAPTERS

Buerger Disease Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-34V5663
Report
October 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Buerger Disease Diagnosis - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Buerger Disease Diagnosis - Market

Buerger Disease Diagnosis - Market

Buerger's disease is a rare disease of the arteries and veins in the arms and legs. It is also called as thromboangiitis obliterans. In Buerger's disease, the blood vessels become inflamed, swell, and get blocked due to blood clots.
The global market for Buerger Disease Diagnosis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Buerger Disease Diagnosis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Buerger Disease Diagnosis by region & country, by Type, and by Application.
The Buerger Disease Diagnosis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buerger Disease Diagnosis.
Market Segmentation

Scope of Buerger Disease Diagnosis - Market Report

Report Metric Details
Report Name Buerger Disease Diagnosis - Market
CAGR 5%
Segment by Type:
  • Blood Tests
  • The Allen’s Test
  • Angiogram
  • Tissue Biopsy
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Medical Research Centers
  • Academic Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company FUJIFILM Holdings Corporation, GE Healthcare, Koninklijke Philips N.V., Pluristem Therapeutics Inc., Shimadzu Corporation, Siemens Healthcare GmbH, Stempeutics Research Pvt. Ltd., Canon Medical Systems Corporation, t2cure GmbH
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Buerger Disease Diagnosis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Buerger Disease Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Buerger Disease Diagnosis in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Buerger Disease Diagnosis - Market report?

Ans: The main players in the Buerger Disease Diagnosis - Market are FUJIFILM Holdings Corporation, GE Healthcare, Koninklijke Philips N.V., Pluristem Therapeutics Inc., Shimadzu Corporation, Siemens Healthcare GmbH, Stempeutics Research Pvt. Ltd., Canon Medical Systems Corporation, t2cure GmbH

What are the Application segmentation covered in the Buerger Disease Diagnosis - Market report?

Ans: The Applications covered in the Buerger Disease Diagnosis - Market report are Hospitals, Clinics, Medical Research Centers, Academic Institutes, Others

What are the Type segmentation covered in the Buerger Disease Diagnosis - Market report?

Ans: The Types covered in the Buerger Disease Diagnosis - Market report are Blood Tests, The Allen’s Test, Angiogram, Tissue Biopsy, Others

1 Market Overview
1.1 Buerger Disease Diagnosis Product Introduction
1.2 Global Buerger Disease Diagnosis Market Size Forecast
1.3 Buerger Disease Diagnosis Market Trends & Drivers
1.3.1 Buerger Disease Diagnosis Industry Trends
1.3.2 Buerger Disease Diagnosis Market Drivers & Opportunity
1.3.3 Buerger Disease Diagnosis Market Challenges
1.3.4 Buerger Disease Diagnosis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Buerger Disease Diagnosis Players Revenue Ranking (2023)
2.2 Global Buerger Disease Diagnosis Revenue by Company (2019-2024)
2.3 Key Companies Buerger Disease Diagnosis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Buerger Disease Diagnosis Product Offered
2.5 Key Companies Time to Begin Mass Production of Buerger Disease Diagnosis
2.6 Buerger Disease Diagnosis Market Competitive Analysis
2.6.1 Buerger Disease Diagnosis Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Buerger Disease Diagnosis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buerger Disease Diagnosis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Blood Tests
3.1.2 The Allen’s Test
3.1.3 Angiogram
3.1.4 Tissue Biopsy
3.1.5 Others
3.2 Global Buerger Disease Diagnosis Sales Value by Type
3.2.1 Global Buerger Disease Diagnosis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Buerger Disease Diagnosis Sales Value, by Type (2019-2030)
3.2.3 Global Buerger Disease Diagnosis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Medical Research Centers
4.1.4 Academic Institutes
4.1.5 Others
4.2 Global Buerger Disease Diagnosis Sales Value by Application
4.2.1 Global Buerger Disease Diagnosis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Buerger Disease Diagnosis Sales Value, by Application (2019-2030)
4.2.3 Global Buerger Disease Diagnosis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Buerger Disease Diagnosis Sales Value by Region
5.1.1 Global Buerger Disease Diagnosis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Buerger Disease Diagnosis Sales Value by Region (2019-2024)
5.1.3 Global Buerger Disease Diagnosis Sales Value by Region (2025-2030)
5.1.4 Global Buerger Disease Diagnosis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Buerger Disease Diagnosis Sales Value, 2019-2030
5.2.2 North America Buerger Disease Diagnosis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Buerger Disease Diagnosis Sales Value, 2019-2030
5.3.2 Europe Buerger Disease Diagnosis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Buerger Disease Diagnosis Sales Value, 2019-2030
5.4.2 Asia Pacific Buerger Disease Diagnosis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Buerger Disease Diagnosis Sales Value, 2019-2030
5.5.2 South America Buerger Disease Diagnosis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Buerger Disease Diagnosis Sales Value, 2019-2030
5.6.2 Middle East & Africa Buerger Disease Diagnosis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Buerger Disease Diagnosis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Buerger Disease Diagnosis Sales Value
6.3 United States
6.3.1 United States Buerger Disease Diagnosis Sales Value, 2019-2030
6.3.2 United States Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Buerger Disease Diagnosis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Buerger Disease Diagnosis Sales Value, 2019-2030
6.4.2 Europe Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Buerger Disease Diagnosis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Buerger Disease Diagnosis Sales Value, 2019-2030
6.5.2 China Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Buerger Disease Diagnosis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Buerger Disease Diagnosis Sales Value, 2019-2030
6.6.2 Japan Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Buerger Disease Diagnosis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Buerger Disease Diagnosis Sales Value, 2019-2030
6.7.2 South Korea Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Buerger Disease Diagnosis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Buerger Disease Diagnosis Sales Value, 2019-2030
6.8.2 Southeast Asia Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Buerger Disease Diagnosis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Buerger Disease Diagnosis Sales Value, 2019-2030
6.9.2 India Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Buerger Disease Diagnosis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 FUJIFILM Holdings Corporation
7.1.1 FUJIFILM Holdings Corporation Profile
7.1.2 FUJIFILM Holdings Corporation Main Business
7.1.3 FUJIFILM Holdings Corporation Buerger Disease Diagnosis Products, Services and Solutions
7.1.4 FUJIFILM Holdings Corporation Buerger Disease Diagnosis Revenue (US$ Million) & (2019-2024)
7.1.5 FUJIFILM Holdings Corporation Recent Developments
7.2 GE Healthcare
7.2.1 GE Healthcare Profile
7.2.2 GE Healthcare Main Business
7.2.3 GE Healthcare Buerger Disease Diagnosis Products, Services and Solutions
7.2.4 GE Healthcare Buerger Disease Diagnosis Revenue (US$ Million) & (2019-2024)
7.2.5 GE Healthcare Recent Developments
7.3 Koninklijke Philips N.V.
7.3.1 Koninklijke Philips N.V. Profile
7.3.2 Koninklijke Philips N.V. Main Business
7.3.3 Koninklijke Philips N.V. Buerger Disease Diagnosis Products, Services and Solutions
7.3.4 Koninklijke Philips N.V. Buerger Disease Diagnosis Revenue (US$ Million) & (2019-2024)
7.3.5 Pluristem Therapeutics Inc. Recent Developments
7.4 Pluristem Therapeutics Inc.
7.4.1 Pluristem Therapeutics Inc. Profile
7.4.2 Pluristem Therapeutics Inc. Main Business
7.4.3 Pluristem Therapeutics Inc. Buerger Disease Diagnosis Products, Services and Solutions
7.4.4 Pluristem Therapeutics Inc. Buerger Disease Diagnosis Revenue (US$ Million) & (2019-2024)
7.4.5 Pluristem Therapeutics Inc. Recent Developments
7.5 Shimadzu Corporation
7.5.1 Shimadzu Corporation Profile
7.5.2 Shimadzu Corporation Main Business
7.5.3 Shimadzu Corporation Buerger Disease Diagnosis Products, Services and Solutions
7.5.4 Shimadzu Corporation Buerger Disease Diagnosis Revenue (US$ Million) & (2019-2024)
7.5.5 Shimadzu Corporation Recent Developments
7.6 Siemens Healthcare GmbH
7.6.1 Siemens Healthcare GmbH Profile
7.6.2 Siemens Healthcare GmbH Main Business
7.6.3 Siemens Healthcare GmbH Buerger Disease Diagnosis Products, Services and Solutions
7.6.4 Siemens Healthcare GmbH Buerger Disease Diagnosis Revenue (US$ Million) & (2019-2024)
7.6.5 Siemens Healthcare GmbH Recent Developments
7.7 Stempeutics Research Pvt. Ltd.
7.7.1 Stempeutics Research Pvt. Ltd. Profile
7.7.2 Stempeutics Research Pvt. Ltd. Main Business
7.7.3 Stempeutics Research Pvt. Ltd. Buerger Disease Diagnosis Products, Services and Solutions
7.7.4 Stempeutics Research Pvt. Ltd. Buerger Disease Diagnosis Revenue (US$ Million) & (2019-2024)
7.7.5 Stempeutics Research Pvt. Ltd. Recent Developments
7.8 Canon Medical Systems Corporation
7.8.1 Canon Medical Systems Corporation Profile
7.8.2 Canon Medical Systems Corporation Main Business
7.8.3 Canon Medical Systems Corporation Buerger Disease Diagnosis Products, Services and Solutions
7.8.4 Canon Medical Systems Corporation Buerger Disease Diagnosis Revenue (US$ Million) & (2019-2024)
7.8.5 Canon Medical Systems Corporation Recent Developments
7.9 t2cure GmbH
7.9.1 t2cure GmbH Profile
7.9.2 t2cure GmbH Main Business
7.9.3 t2cure GmbH Buerger Disease Diagnosis Products, Services and Solutions
7.9.4 t2cure GmbH Buerger Disease Diagnosis Revenue (US$ Million) & (2019-2024)
7.9.5 t2cure GmbH Recent Developments
8 Industry Chain Analysis
8.1 Buerger Disease Diagnosis Industrial Chain
8.2 Buerger Disease Diagnosis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Buerger Disease Diagnosis Sales Model
8.5.2 Sales Channel
8.5.3 Buerger Disease Diagnosis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Buerger Disease Diagnosis Market Trends
    Table 2. Buerger Disease Diagnosis Market Drivers & Opportunity
    Table 3. Buerger Disease Diagnosis Market Challenges
    Table 4. Buerger Disease Diagnosis Market Restraints
    Table 5. Global Buerger Disease Diagnosis Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Buerger Disease Diagnosis Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Buerger Disease Diagnosis Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Buerger Disease Diagnosis Product Type
    Table 9. Key Companies Time to Begin Mass Production of Buerger Disease Diagnosis
    Table 10. Global Buerger Disease Diagnosis Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buerger Disease Diagnosis as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Buerger Disease Diagnosis Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Buerger Disease Diagnosis Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Buerger Disease Diagnosis Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Buerger Disease Diagnosis Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Buerger Disease Diagnosis Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Buerger Disease Diagnosis Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Buerger Disease Diagnosis Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Buerger Disease Diagnosis Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Buerger Disease Diagnosis Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Buerger Disease Diagnosis Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Buerger Disease Diagnosis Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Buerger Disease Diagnosis Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Buerger Disease Diagnosis Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Buerger Disease Diagnosis Sales Value by Region (2019-2024) & (%)
    Table 27. Global Buerger Disease Diagnosis Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Buerger Disease Diagnosis Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Buerger Disease Diagnosis Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Buerger Disease Diagnosis Sales Value, (2025-2030) & (US$ Million)
    Table 31. FUJIFILM Holdings Corporation Basic Information List
    Table 32. FUJIFILM Holdings Corporation Description and Business Overview
    Table 33. FUJIFILM Holdings Corporation Buerger Disease Diagnosis Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Buerger Disease Diagnosis Business of FUJIFILM Holdings Corporation (2019-2024)
    Table 35. FUJIFILM Holdings Corporation Recent Developments
    Table 36. GE Healthcare Basic Information List
    Table 37. GE Healthcare Description and Business Overview
    Table 38. GE Healthcare Buerger Disease Diagnosis Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Buerger Disease Diagnosis Business of GE Healthcare (2019-2024)
    Table 40. GE Healthcare Recent Developments
    Table 41. Koninklijke Philips N.V. Basic Information List
    Table 42. Koninklijke Philips N.V. Description and Business Overview
    Table 43. Koninklijke Philips N.V. Buerger Disease Diagnosis Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Buerger Disease Diagnosis Business of Koninklijke Philips N.V. (2019-2024)
    Table 45. Koninklijke Philips N.V. Recent Developments
    Table 46. Pluristem Therapeutics Inc. Basic Information List
    Table 47. Pluristem Therapeutics Inc. Description and Business Overview
    Table 48. Pluristem Therapeutics Inc. Buerger Disease Diagnosis Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Buerger Disease Diagnosis Business of Pluristem Therapeutics Inc. (2019-2024)
    Table 50. Pluristem Therapeutics Inc. Recent Developments
    Table 51. Shimadzu Corporation Basic Information List
    Table 52. Shimadzu Corporation Description and Business Overview
    Table 53. Shimadzu Corporation Buerger Disease Diagnosis Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Buerger Disease Diagnosis Business of Shimadzu Corporation (2019-2024)
    Table 55. Shimadzu Corporation Recent Developments
    Table 56. Siemens Healthcare GmbH Basic Information List
    Table 57. Siemens Healthcare GmbH Description and Business Overview
    Table 58. Siemens Healthcare GmbH Buerger Disease Diagnosis Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Buerger Disease Diagnosis Business of Siemens Healthcare GmbH (2019-2024)
    Table 60. Siemens Healthcare GmbH Recent Developments
    Table 61. Stempeutics Research Pvt. Ltd. Basic Information List
    Table 62. Stempeutics Research Pvt. Ltd. Description and Business Overview
    Table 63. Stempeutics Research Pvt. Ltd. Buerger Disease Diagnosis Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Buerger Disease Diagnosis Business of Stempeutics Research Pvt. Ltd. (2019-2024)
    Table 65. Stempeutics Research Pvt. Ltd. Recent Developments
    Table 66. Canon Medical Systems Corporation Basic Information List
    Table 67. Canon Medical Systems Corporation Description and Business Overview
    Table 68. Canon Medical Systems Corporation Buerger Disease Diagnosis Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Buerger Disease Diagnosis Business of Canon Medical Systems Corporation (2019-2024)
    Table 70. Canon Medical Systems Corporation Recent Developments
    Table 71. t2cure GmbH Basic Information List
    Table 72. t2cure GmbH Description and Business Overview
    Table 73. t2cure GmbH Buerger Disease Diagnosis Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Buerger Disease Diagnosis Business of t2cure GmbH (2019-2024)
    Table 75. t2cure GmbH Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Buerger Disease Diagnosis Downstream Customers
    Table 79. Buerger Disease Diagnosis Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Buerger Disease Diagnosis Product Picture
    Figure 2. Global Buerger Disease Diagnosis Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Buerger Disease Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 4. Buerger Disease Diagnosis Report Years Considered
    Figure 5. Global Buerger Disease Diagnosis Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Buerger Disease Diagnosis Revenue in 2023
    Figure 7. Buerger Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Blood Tests Picture
    Figure 9. The Allen’s Test Picture
    Figure 10. Angiogram Picture
    Figure 11. Tissue Biopsy Picture
    Figure 12. Others Picture
    Figure 13. Global Buerger Disease Diagnosis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Buerger Disease Diagnosis Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Hospitals
    Figure 16. Product Picture of Clinics
    Figure 17. Product Picture of Medical Research Centers
    Figure 18. Product Picture of Academic Institutes
    Figure 19. Product Picture of Others
    Figure 20. Global Buerger Disease Diagnosis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Buerger Disease Diagnosis Sales Value Market Share by Application, 2023 & 2030
    Figure 22. North America Buerger Disease Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 23. North America Buerger Disease Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 24. Europe Buerger Disease Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 25. Europe Buerger Disease Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 26. Asia Pacific Buerger Disease Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 27. Asia Pacific Buerger Disease Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 28. South America Buerger Disease Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 29. South America Buerger Disease Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 30. Middle East & Africa Buerger Disease Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 31. Middle East & Africa Buerger Disease Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 32. Key Countries/Regions Buerger Disease Diagnosis Sales Value (%), (2019-2030)
    Figure 33. United States Buerger Disease Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 34. United States Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 35. United States Buerger Disease Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 36. Europe Buerger Disease Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Europe Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 38. Europe Buerger Disease Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 39. China Buerger Disease Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 40. China Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 41. China Buerger Disease Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 42. Japan Buerger Disease Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Japan Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 44. Japan Buerger Disease Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 45. South Korea Buerger Disease Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 46. South Korea Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 47. South Korea Buerger Disease Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 48. Southeast Asia Buerger Disease Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 50. Southeast Asia Buerger Disease Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 51. India Buerger Disease Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 52. India Buerger Disease Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 53. India Buerger Disease Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 54. Buerger Disease Diagnosis Industrial Chain
    Figure 55. Buerger Disease Diagnosis Manufacturing Cost Structure
    Figure 56. Channels of Distribution (Direct Sales, and Distribution)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Hematologic Malignancies Detection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-20M14708
Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Add to Cart

Add to Cart

Add to Cart